Omnicell, Inc. (OMCL) vs Phreesia, Inc. (PHR)
- Omnicell, Inc. OMCL 35.39 −1.56%
- Phreesia, Inc. PHR 10.94 −0.91%
Omnicell, Inc. and Phreesia, Inc. are both Health Information Services companies. Omnicell, Inc. is the larger, with a market value of $1.6B against $685.3M — 2.4× the size. Omnicell, Inc. trades at the lower P/E: 41.6× against 64.4×. Phreesia, Inc. grew revenue faster over the last twelve months: 12.9% against 8.45%. Omnicell, Inc. has the higher net margin (3.13% vs 2.06%) and the higher return on invested capital (3.10% vs 1.74%). Across the 22 metrics below, Omnicell, Inc. leads on 11 and Phreesia, Inc. on 11.
Valuation
Profitability
| Metric | OMCL | PHR | Health Information Services median |
|---|---|---|---|
| Gross margin | 44.77% | 67.52% | 62.87% |
| Operating margin | 4.65% | 2.47% | (9.45%) |
| Net margin | 3.13% | 2.06% | (15.48%) |
| Free cash flow margin | 10.17% | 13.30% | 0.00% |
| Return on equity | 3.06% | 3.12% | (6.91%) |
| Return on assets | 1.89% | 1.98% | (6.28%) |
| Return on invested capital | 3.10% | 1.74% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack